Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone
Archives of Virology · 2023
DOI: 10.1007/s00705-022-05696-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2023. Verfasst von Georgios-Dimitrios Panagiotidis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, 35392, Giessen, Germany. Hauptthemen laut MEDLINE: Influenza A virus, Paliperidone Palmitate, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Infektionsforschung, Justus-Liebig-Universität Gießen.
Abstract (Originalsprache)
Influenza A virus (FLUAV) is a significant human pathogen. In silico structural analysis (PMID 28628827) has suggested that the FDA-approved drug paliperidone interferes with the binding of the FLUAV polymerase subunit PB2 to the nucleoprotein NP. We found that paliperidone inhibits FLUAV A/PR/8/34 early after infection of canine MDCK II, human A549, and human primary bronchial cells, but not at late time points. No effect was detectable against the strains A/Hamburg/05/2009 and A/WSN/33. Moreover, paliperidone indeed disturbed the interaction between the PB2 and the NP of A/PR/8/34 and reduced early viral RNA and protein synthesis by approximately 50%. Thus, paliperidone has measurable but transient and virus-strain-restricted effects on FLUAV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, 35392, Giessen, Germany.
- Institute for Medical Virology, FB11-Medicine, Justus-Liebig University, 35392, Giessen, Germany.
- German Center for Infection Research (DZIF), Partner Site Giessen, Germany.
- Research Group "Dynamics of early viral infection and the innate antiviral response", Division "Virus-Associated Carcinogenesis", German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, 35392, Giessen, Germany. friedemann.weber@vetmed.uni-giessen.de.
- German Center for Infection Research (DZIF), Partner Site Giessen, Germany. friedemann.weber@vetmed.uni-giessen.de.
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsches Zentrum für Infektionsforschung
- Justus-Liebig-Universität Gießen
Zitieren
APA
Panagiotidis, G. D., Müller, C., Binder, M., & Weber, F. (2023). Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Archives of Virology. https://doi.org/10.1007/s00705-022-05696-0
Vancouver
Panagiotidis GD, Müller C, Binder M, Weber F. Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Archives of Virology. 2023. doi:10.1007/s00705-022-05696-0
BibTeX
@article{Panagiotidis2023,
author = {Panagiotidis, Georgios-Dimitrios and Müller, Christin and Binder, Marco and Weber, Friedemann},
title = {Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone},
journal = {Archives of Virology},
year = {2023},
doi = {10.1007/s00705-022-05696-0}
}
EUVIMED